Literature DB >> 23318994

Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis.

Pallavi Chaturvedi1, Daniele M Gilkes, Carmen Chak Lui Wong, Weibo Luo, Huafeng Zhang, Hong Wei, Naoharu Takano, Luana Schito, Andre Levchenko, Gregg L Semenza.   

Abstract

Metastasis involves critical interactions between cancer and stromal cells. Intratumoral hypoxia promotes metastasis through activation of hypoxia-inducible factors (HIFs). We demonstrate that HIFs mediate paracrine signaling between breast cancer cells (BCCs) and mesenchymal stem cells (MSCs) to promote metastasis. In a mouse orthotopic implantation model, MSCs were recruited to primary breast tumors and promoted BCC metastasis to LNs and lungs in a HIF-dependent manner. Coculture of MSCs with BCCs augmented HIF activity in BCCs. Additionally, coculture induced expression of the chemokine CXCL10 in MSCs and the cognate receptor CXCR3 in BCCs, which was augmented by hypoxia. CXCR3 expression was blocked in cocultures treated with neutralizing antibody against CXCL10. Conversely, CXCL10 expression was blocked in MSCs cocultured with BCCs that did not express CXCR3 or HIFs. MSC coculture did not enhance the metastasis of HIF-deficient BCCs. BCCs and MSCs expressed placental growth factor (PGF) and its cognate receptor VEGFR1, respectively, in a HIF-dependent manner, and CXCL10 expression by MSCs was dependent on PGF expression by BCCs. PGF promoted metastasis of BCCs and also facilitated homing of MSCs to tumors. Thus, HIFs mediate complex and bidirectional paracrine signaling between BCCs and MSCs that stimulates breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23318994      PMCID: PMC3533298          DOI: 10.1172/JCI64993

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.

Authors:  Brenda L Petrella; Jouko Lohi; Constance E Brinckerhoff
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

2.  Lysyl oxidase is essential for hypoxia-induced metastasis.

Authors:  Janine T Erler; Kevin L Bennewith; Monica Nicolau; Nadja Dornhöfer; Christina Kong; Quynh-Thu Le; Jen-Tsan Ashley Chi; Stefanie S Jeffrey; Amato J Giaccia
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

3.  Breast tumor cell lines from pleural effusions.

Authors:  R Cailleau; R Young; M Olivé; W J Reeves
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

4.  Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.

Authors:  Jean-Philippe Dales; Stéphane Garcia; Séverine Meunier-Carpentier; Lucile Andrac-Meyer; Olivier Haddad; Marie-Noölle Lavaut; Claude Allasia; Pascal Bonnier; Colette Charpin
Journal:  Int J Cancer       Date:  2005-09-20       Impact factor: 7.396

Review 5.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 6.  Hypoxia-driven selection of the metastatic phenotype.

Authors:  Richard Sullivan; Charles H Graham
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

7.  Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.

Authors:  Karolina Helczynska; Anna-Maria Larsson; Linda Holmquist Mengelbier; Esther Bridges; Erik Fredlund; Signe Borgquist; Göran Landberg; Sven Påhlman; Karin Jirström
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

Review 8.  Detection and characterization of tumor hypoxia using pO2 histography.

Authors:  Peter Vaupel; Michael Höckel; Arnulf Mayer
Journal:  Antioxid Redox Signal       Date:  2007-08       Impact factor: 8.401

9.  HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.

Authors:  H Zhang; C C L Wong; H Wei; D M Gilkes; P Korangath; P Chaturvedi; L Schito; J Chen; B Krishnamachary; P T Winnard; V Raman; L Zhen; W A Mitzner; S Sukumar; G L Semenza
Journal:  Oncogene       Date:  2011-08-22       Impact factor: 9.867

10.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

View more
  121 in total

1.  Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer.

Authors:  Daniel Delitto; Chelsey Perez; Song Han; David H Gonzalo; Kien Pham; Andrea E Knowlton; Christina L Graves; Kevin E Behrns; Lyle L Moldawer; Ryan M Thomas; Chen Liu; Thomas J George; Jose G Trevino; Shannon M Wallet; Steven J Hughes
Journal:  Cancer Immunol Immunother       Date:  2015-09-30       Impact factor: 6.968

2.  Hypoxia-induced secretion of IL-10 from adipose-derived mesenchymal stem cell promotes growth and cancer stem cell properties of Burkitt lymphoma.

Authors:  Lihua Xu; Xu Wang; Jiani Wang; Dan Liu; Yaya Wang; Zhenqian Huang; Huo Tan
Journal:  Tumour Biol       Date:  2015-12-23

Review 3.  HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.

Authors:  Gregg L Semenza
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

4.  Extracellular volatilomic alterations induced by hypoxia in breast cancer cells.

Authors:  Ravindra Taware; Khushman Taunk; Totakura V S Kumar; Jorge A M Pereira; José S Câmara; H A Nagarajaram; Gopal C Kundu; Srikanth Rapole
Journal:  Metabolomics       Date:  2020-01-24       Impact factor: 4.290

5.  Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes.

Authors:  Joo Young Kim; Sun-Hee Heo; Seul Ki Choi; In Hye Song; In Ah Park; Young-Ae Kim; Hye Seon Park; Suk Young Park; Won Seon Bang; Gyungyub Gong; Hee Jin Lee
Journal:  Virchows Arch       Date:  2017-02-09       Impact factor: 4.064

6.  O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo.

Authors:  Daniel M Lewis; Michael R Blatchley; Kyung Min Park; Sharon Gerecht
Journal:  Nat Protoc       Date:  2017-07-20       Impact factor: 13.491

Review 7.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

8.  Chaperone-mediated autophagy targets hypoxia-inducible factor-1α (HIF-1α) for lysosomal degradation.

Authors:  Maimon E Hubbi; Hongxia Hu; Ishrat Ahmed; Andre Levchenko; Gregg L Semenza
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

9.  Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.

Authors:  Ting Wang; Daniele M Gilkes; Naoharu Takano; Lisha Xiang; Weibo Luo; Corey J Bishop; Pallavi Chaturvedi; Jordan J Green; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-17       Impact factor: 11.205

10.  Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts.

Authors:  Daniele M Gilkes; Saumendra Bajpai; Pallavi Chaturvedi; Denis Wirtz; Gregg L Semenza
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.